Sirtuin 5 Alleviates Liver Ischemia/Reperfusion Injury by Regulating Mitochondrial Succinylation and Oxidative Stress
Antioxidants & Redox Signaling · 2024
DOI: 10.1089/ars.2022.0137 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants & Redox Signaling, 2024. Verfasst von Yan Hu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Dalian Medical University, Dalian, China. Hauptthemen laut MEDLINE: Liver Diseases, Reperfusion Injury, Sirtuins. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 71 Literaturangaben.
Abstract (Originalsprache)
Aims
Mitochondrial dysfunction is the primary mechanism of liver ischemia/reperfusion (I/R) injury. The lysine desuccinylase sirtuin 5 (SIRT5) is a global regulator of the mitochondrial succinylome and has pivotal roles in mitochondrial metabolism and function; however, its hepatoprotective capacity in liver I/R remains unclear. In this study, we established liver I/R model in SIRT5-silenced and SIRT5-overexpressed mice to examine the role and precise mechanisms of SIRT5 in liver I/R injury.
Results
Succinylation was strongly enriched in liver mitochondria during I/R, and inhibiting mitochondrial succinylation significantly attenuated liver I/R injury. Importantly, the levels of the desuccinylase SIRT5 were notably decreased in liver transplant patients, as well as in mice subjected to I/R and in AML12 cells exposed to hypoxia/reoxygenation. Furthermore, SIRT5 significantly ameliorated liver I/R-induced oxidative injury, apoptosis, and inflammation by regulating mitochondrial oxidative stress and function. Intriguingly, the hepatoprotective effect of SIRT5 was mediated by PRDX3. Mechanistically, SIRT5 specifically desuccinylated PRDX3 at the K84 site, which enabled PRDX3 to alleviate mitochondrial oxidative stress during liver I/R. Innovation: This study denoted the new effect and mechanism of SIRT5 in regulating mitochondrial oxidative stress through lysine desuccinylation, thus preventing liver I/R injury.
Conclusions
Our findings demonstrate for the first time that SIRT5 is a key mediator of liver I/R that regulates mitochondrial oxidative stress through the desuccinylation of PRDX3, which provides a novel strategy to prevent liver I/R injury. Antioxid. Redox Signal. 40, 616–631.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Dalian Medical University, Dalian, China.
- Department of Pharmacy, The Second Affiliated Hospital of Dalian Medical University, Dalian, China.
- Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Department of General Surgery, The Second Affiliated Hospital of Dalian Medical University, Dalian, China.
- Departments of Hepatobiliary and Pancreatic Surgery and Liver Transplantation, Shulan (Hangzhou) Hospital, Hangzhou, China.
ORCID-Profile: Jihong Yao
Zitieren
APA
Hu, Y., Tian, X., Zhao, Y., Wang, Z., Lin, M., Sun, R., Wang, Y., Wang, Z., Li, G., Zheng, S., & Yao, J. (2024). Sirtuin 5 Alleviates Liver Ischemia/Reperfusion Injury by Regulating Mitochondrial Succinylation and Oxidative Stress. Antioxidants & Redox Signaling. https://doi.org/10.1089/ars.2022.0137
Vancouver
Hu Y, Tian X, Zhao Y, Wang Z, Lin M, Sun R, et al. Sirtuin 5 Alleviates Liver Ischemia/Reperfusion Injury by Regulating Mitochondrial Succinylation and Oxidative Stress. Antioxidants & Redox Signaling. 2024. doi:10.1089/ars.2022.0137
BibTeX
@article{Hu2024,
author = {Hu, Yan and Tian, Xinyao and Zhao, Yan and Wang, Zhecheng and Lin, Musen and Sun, Ruimin and Wang, Yue and Wang, Zhanyu and Li, Guiru and Zheng, Shusen and Yao, Jihong},
title = {Sirtuin 5 Alleviates Liver Ischemia/Reperfusion Injury by Regulating Mitochondrial Succinylation and Oxidative Stress},
journal = {Antioxidants & Redox Signaling},
year = {2024},
doi = {10.1089/ars.2022.0137}
}
EUVIMED